Filter by: Subject

Filter by: Subject

Results Per Page:

Positron emission tomography (PET) (7)
Prostate-specific membrane antigen (PSMA) (4)
Biodistribution (3)
Infection (3)
PET/CT (3)
Prostate cancer (3)
68Ga (2)
68Ga-PSMA (2)
Antimicrobial peptide (AMP) (2)
DOTA (2)
In vivo (2)
Infection imaging (2)
Microemulsion (2)
NODAGA (2)
Positron emission tomography/computed tomography (PET/CT) (2)
Radiolabeling (2)
Radiotracers (2)
Ubiquicidin (2)
195mPt-cisplatinum (1)
68Ga labeling (1)
68Ga-DKFZ-PSMA-11 (1)
68Ga-HBED-CC-(Ahx)Lys-NH-CO-NH-Glu (1)
68Ga-NOTA-UBI (1)
68Ga-PSMAHBED (1)
68Ga/68Ge generator (1)
68Gallium (1)
68Ga‐PSMA‐617 (1)
68Ge/68Ga generator (1)
[213Bi]Bi-1,4,7,10- tetraazacyclododecane-1,4,7,10-tetraacetic acid-[Thi8 , Met(O2 ) 11]-Substance-P (1)
[68Ga]Ga-PSMA-617-ME (1)
[68Ga]Ga1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-[Thi8 , Met(O2 ) 11]-Substance-P (1)
[89Zr]IIIB6 (1)
Africa (1)
Alpha(nu)beta(3)-integrin (1)
Angiogenesis (1)
Angiotensin-converting enzyme 2 (ACE2) (1)
Antibiotic-derived PET (1)
Antimicrobial peptides (1)
Arterial inflammation (1)
Atherosclerotic cardiovascular disease (ASCVD) (1)
Atherosclerotic cardiovascular diseases (1)
Bacteria (1)
Black South-African (BSAs) (1)
Breast cancer (1)
Cardiac implantable electronic device (CIED) (1)
Cathelicidin (1)
Cathelicidin-derived peptide (CDP1) (1)
CDP1 (1)
Chemotherapy -- Research -- South Africa (1)
Cisplatin (1)
Companion diagnostic (1)
Computerized tomography (CT) (1)
Coronavirus disease 2019 (COVID-19) (1)
COVID-19 pandemic (1)
Cytokine storm (1)
Depsidomycin-derived compounds (1)
Depsipeptides (1)
Diagnosis (1)
DOTA-Substance P (1)
DOTA-TBIA101 (1)
Drug carrier system (1)
Drug delivery (1)
Epigenetics (1)
Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography ([18F]FDG PET/CT) (1)
Fluorine-18 ubiquicidin (1)
Gallium-68 (1)
Gallium-68 (Ga-68) (1)
Gallium-68 pentixafor positron emission tomography/computed tomography ([68Ga]Ga-pentixafor PET/CT) (1)
Gallium-68 ubiquicidin (1)
Genotoxicity (1)
Good manufacturing practice (GMP) (1)
Good radiopharmacy practice (GRRP) (1)
HIV infection (1)
Human immunodeficiency virus (HIV) (1)
Iinfection imaging (1)
Imaging (1)
Imaging of infection (1)
In vitro (1)
In vivo toxicity (1)
Infection-selective tracers (1)
Infectious diseases (1)
Infective endocarditis (1)
Inflamation (1)
Inflammation (1)
Kit preparation (1)
Left ventricular assist device (1)
LL37 (1)
Lung cancer (1)
Medicine (1)
Micro-PET/CT imaging (1)
MicroPET/CT (1)
Molecular imaging (1)
Multi-organ (1)
Nanomedicine (1)
Nanoparticles (1)
Nimotuzumab (1)
NOTA (1)
Nota-RGD (1)
Nuclear medicine (1)
OECD guidelines (1)